Sumatriptan Tablet
Product Images NDC 63187-797

4 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 63187-797). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sumatriptan Str)

Chemical Structure (Sumatriptan Str)
Chemical structure of Sumatriptan Succinate, the active ingredient in Sumatriptan 50 mg tablets by Proficient Rx LP.*
FDA Label Image

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)
A line graph showing the estimated probability of response over time in minutes from the initial dose for Sumatriptan at 25 mg, 50 mg, and 100 mg doses, compared to placebo. The graph depicts higher response probabilities with increasing dosage and time.*
FDA Label Image

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig2)

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig2)
A line graph showing the estimated probability of headache or facial pain remediation over 24 hours after initial dose, comparing placebo and varying doses (25 mg, 50 mg, 100 mg) of Sumatriptan. The y-axis represents the estimated probability as a percentage, and the x-axis represents time in hours from the initial dose.*
FDA Label Image

63187-797-09 (Sumatriptan Fig4)

63187-797-09 (Sumatriptan Fig4)
Label for Sumatriptan 50 mg tablets, an oral prescription drug by Proficient Rx LP. The label includes dosage strength, tablet description (white to off-white, capsule shaped, biconvex, uncoated with debossed markings), manufacturer Aurobindo Pharma Limited, and storage instructions. It includes NDC 63187-797 and batch information placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.